A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.
Opportunity knocks thrice for the iconic growth investor.
The study will compare NHS and social data to track long term impact of childhood blood disorders.
15hon MSN
This 11-year-old has battled a rare disease for years — a breakthrough drug helped deliver relief
Actor turned rare disease advocate Luke Rosen tells how his daughter, Susannah, lives with a KIF1A-associated neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results